返回
Hansoh Pharmaceutical Group Company Limited（3692.HK）價格
3692.HK 股價走勢圖
HANSOH PHARMA (3692.HK)
Hansoh Pharmaceutical Group Company Limited
HK$43
-0.18%
$-0.07
休市： Jan 16, 16:00:00 HKT
A+
最終分數
關鍵數據
前收市價
$43.12
開盤價
$43.08
當日範圍
$42.3 - $43.08
52週區間
$16.7 - $44.22
交易量
3.7M
平均成交量
8.3M
每股盈餘 (TTM)
0.89
股息收益率
--
市值
$255.6B
什麼是 HANSOH PHARMA？
Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 9,313 full-time employees. The company went IPO on 2019-06-14. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The firm mainly conducts its business in the domestic market.
